Induction of Colitis by a CD4 T Cell Clone Specific for a Bacterial Epitope

Total Page:16

File Type:pdf, Size:1020Kb

Induction of Colitis by a CD4 T Cell Clone Specific for a Bacterial Epitope Induction of colitis by a CD4؉ T cell clone specific for a bacterial epitope Marika C. Kullberg*†, John F. Andersen‡, Peter L. Gorelick§, Patricia Caspar*, Sebastian Suerbaum¶ʈ, James G. Fox**, Allen W. Cheever††, Dragana Jankovic*, and Alan Sher* *Immunobiology Section and ‡Laboratory of Malaria and Vector Research, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; §Animal Health Diagnostic Laboratory, Laboratory Animal Sciences Program, National Cancer Institute, SAIC, Frederick, MD 21702; ¶Institute of Hygiene and Microbiology, University of Wu¨rzburg, D-97080 Wu¨rzburg, Germany; **Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA 02139; and ††The Biomedical Research Institute, Rockville, MD 20852 Edited by Howard M. Grey, La Jolla Institute for Allergy and Immunology, San Diego, CA, and approved October 23, 2003 (received for review July 18, 2003) It is now well established that the intestinal flora plays an impor- IL-10 KO animals, but not simultaneously infected WT mice, tant role in the pathogenesis of inflammatory bowel disease (IBD). display marked inflammation in the cecum and colon (13). This However, whether bacteria serve as the sole target of the immune colitis is associated with a T helper 1 (Th1)-type cytokine response in this process or whether they act indirectly by triggering response to SHelAg, a soluble H. hepaticus Ag preparation, and an anti-self response is still unclear. We have previously shown treatment with anti-IL-12 mAb from the start of the infection or that specific pathogen-free IL-10-deficient (IL-10 KO) mice develop once disease is established reduces the inflammation as well as a T helper (Th1)-cytokine associated colitis after experimental the SHelAg-induced IFN-␥ production (13, 14). Together these infection with Helicobacter hepaticus. We here show that H. studies indicate a strong correlation between the Th1-type ؉ hepaticus Ag (SHelAg)-specific CD4 Th1 clones transfer disease to response to the bacterium and disease severity. H. hepaticus-infected T cell-deficient RAG KO hosts. Importantly, In the present study we have investigated the role of the uninfected recipients of the SHelAg-specific clones did not develop microbial-specific T cell response in the development of H. intestinal inflammation, and a control Schistosoma mansoni- hepaticus-induced colitis. In particular, we have addressed the specific Th1 clone did not induce colitis upon transfer to infected question of whether an aberrant T cell response directed exclu- RAG KO mice. The disease-inducing T cell clones recognized anti- sively against this bacterium is sufficient to trigger intestinal gen(s) (Ag) specifically expressed by certain Helicobacter species as inflammation. By transferring SHelAg-specific T cell clones into they responded when stimulated in vitro with H. hepaticus and T cell-deficient hosts, we demonstrate that colitis can develop as Helicobacter typhlonius Ag, but not when cultured with Ag prep- a result of an immune response directed solely against gut arations from Helicobacter pylori, various non-helicobacter bacte- bacteria. ria, or with cecal bacterial lysate from uninfected mice. Character- ization of the Ag specificity of one of the clones showed that it Materials and Methods reacts uniquely with a 15-mer peptide epitope on the flagellar Experimental Animals and Infections. Six- to 8-wk-old female spe- hook protein (FlgE) of H. hepaticus presented by I–Ab. Together, cific pathogen-free C57BL͞10 WT, C57BL͞10 IL-10 KO, our results demonstrate that colitis can be induced by clonal T cell C57BL͞10 RAG-2 KO (Taconic Farms), and C57BL͞6J SCID populations that are highly specific for target Ag on intestinal mice (The Jackson Laboratory) were used. The animals tested bacteria, suggesting that an aberrant T cell response directed negative for Ab to specific murine viruses and were free of against gut flora is sufficient to trigger IBD. Helicobacter species as assessed by PCR. All animals were housed in sterile microisolator cages at the National Institute of any inflammatory diseases are now thought to have a Allergy and Infectious Diseases (NIAID) animal facility under Mmicrobial etiology. For example, various bacteria and a study proposal approved by the NIAID Animal Care and Use viruses have been implicated in the development of peptic ulcers, Committee. reactive arthritis, arteriosclerosis, type 1 diabetes, and multiple Mice were inoculated intragastrically with 0.5 ml of an H. sclerosis. One of the best studied examples of the involvement of hepaticus suspension [‘‘NCI-Frederick isolate 1A’’ (15) isolated microbes in disease pathogenesis is inflammatory bowel disease from the same mouse colony as isolate Hh-1 (ATCC51449) (16)] (IBD). IBD is believed to be the result of an aberrant intestinal prepared to a McFarland turbidity standard of 1.0 in PBS mucosal immune response (1–3), and several reports have representing 2.45 ϫ 109 colony-forming units (cfu)͞ml. implicated a role for gut flora in human IBD (3–5). Moreover, studies in experimental models have clearly demonstrated that Antigens. SHelAg was prepared as described (13) and, in certain intestinal flora play a crucial role in IBD pathogenesis because experiments, boiled for 5 min (17). Following the same protocol, specific pathogen-free or germ-free animals develop minimal or Ag was prepared from the following bacteria from the American no disease (6–9). Type Culture Collection: Escherichia coli (ATCC25922), Kleb- Among potential mechanisms by which microbes trigger in- siella pneumoniae (ATCC13883), Pseudomonas aeruginosa flammatory diseases are molecular mimicry, bystander activa- (ATCC27853), Proteus vulgaris (ATCC13315), Staphylococcus tion or epitope spreading, and superantigen activation of T cells (10–12). A key question in the field of IBD is whether the tissue-damaging response is directed against the gut flora itself This paper was submitted directly (Track II) to the PNAS office. or whether it represents an autoimmune reaction triggered by Abbreviations: Ag, antigen; FlgE, flagellar hook protein; IBD, inflammatory bowel disease; microbial costimulation. Although data from experimental mod- OMP, outer membrane protein; SHelAg, soluble Helicobacter hepaticus Ag; Treg, T regu- els suggest that bacterial antigen (Ag) are the initial trigger of T latory cell; KO, knockout; Th1, T helper 1; TCR, T cell receptor; CBL, cecal bacterial lysate. cell activation, it is not clear whether an antibacterial T cell Data deposition: The sequence reported in this paper has been deposited in the GenBank response by itself is sufficient to induce IBD, thus leaving open database (accession no. AJ583505). the question of target Ag(s) and T cell fine specificity. †To whom correspondence should be addressed. E-mail: [email protected]. We have studied a model of IBD involving Helicobacter ʈPresent address: Institute of Medical Microbiology and Hospital Epidemiology, Hannover hepaticus infection of specific pathogen-free IL-10 knockout Medical School, D-30625 Hannover, Germany. (KO) mice. Within weeks after inoculation with this bacterium, © 2003 by The National Academy of Sciences of the USA 15830–15835 ͉ PNAS ͉ December 23, 2003 ͉ vol. 100 ͉ no. 26 www.pnas.org͞cgi͞doi͞10.1073͞pnas.2534546100 Downloaded by guest on September 26, 2021 epidermidis (ATCC12228), Staphylococcus aureus SHelAg (1–10 ␮g͞ml), various bacterial Ag preparations, CBL, (ATCC25923), and Helicobacter muridarum (ATCC51212), or recombinant H. hepaticus proteins, or synthetic peptides. In from Helicobacter typhlonius (18), and Helicobacter pylori (strain some experiments, splenocytes were cultured overnight (107 per G27, cagAϩ) (19). Cecal bacterial lysate (CBL) and Schistosoma ml) in medium, SHelAg (10 ␮g͞ml), or CBL (200 ␮g͞ml), mansoni soluble worm antigen preparation were prepared as irradiated, and washed before addition to wells. When indicated, described (20, 21). Synthetic 15-mer peptides (96–98% pure) 10 ␮g͞ml anti-CD4 (GK1.5), anti-CD8 (2.43), or anti-class II were purchased from Multiple Peptide Systems (San Diego). MHC mAb (M5͞114) were added to cultures. Supernatants were The sequence of the peptide with stimulatory activity was collected after 48–72 h, and IFN-␥ was measured by ELISA confirmed by Edman degradation. using mAb from BD Biosciences. Cloning and Expression of H. hepaticus Flagellar Hook Protein (FlgE). Flow Cytometric Analysis. T cell clones were analyzed for T cell ␤ The flgE gene was amplified from H. hepaticus genomic DNA by receptor (TCR) V expression by using mAb from BD Bio- using gene-specific primers (Table 1, which is published as sciences: phycoerythrin anti-CD4 (RM4-5), Cy-chrome anti- ␤ ␤ ␤ ␤ ␤ ͞ ␤ supporting information on the PNAS web site) designed based TCR V (H57-597), FITC anti-V 2, V 3, V 4, V 5.1 5.2, V 6, ␤ ␤ ͞ ␤ ␤ ␤ ␤ ␤ ␤ ␤ on the H. hepaticus genome sequence (22). PCR products were V 7, V 8.1 8.2, V 8.3, V 9, V 10b, V 11, V 12, V 13, V 14, ␤ cloned into the pCR 4-TOPO vector (Invitrogen). Miniprep or V 17a. DNA was cut with NdeI and XhoI, and inserts were ligated into the expression vector pET17b (Novagen). Recombinant proteins Transfer of T Cell Clones into RAG KO Mice. Twelve to 25 days after ϫ 7 were expressed in E. coli strain BL21(DE3) pLys S (Invitrogen). Ag stimulation, T cell clones (4 10 per mouse) were trans- Isolated inclusion bodies were solubilized (20 mM Tris⅐HCl, pH 8͞10 mM DTT͞6 M guanidinium hydrochloride) and proteins purified by gel filtration (Superdex 200, 20 mM Tris⅐HCl, pH 8͞0.1 M NaCl͞3 M urea). Purified proteins were dialyzed against Tris-buffered saline followed by distilled water. The purity of recombinant proteins was verified by SDS͞PAGE. Generation of T Cell Clones. T cell lines were established from 4-wk H. hepaticus-infected anti-CD8-treated IL-10 KO mice (1 mg of mAb 2.43 i.p. per week). Briefly, mesenteric lymph node cells (3 ϫ 106 per well) were cultured in 24-well plates with 50 ng͞ml SHelAg in complete medium (17).
Recommended publications
  • Food Or Beverage Product, Or Probiotic Composition, Comprising Lactobacillus Johnsonii 456
    (19) TZZ¥¥¥ _T (11) EP 3 536 328 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 11.09.2019 Bulletin 2019/37 A61K 35/74 (2015.01) A61K 35/66 (2015.01) A61P 35/00 (2006.01) (21) Application number: 19165418.5 (22) Date of filing: 19.02.2014 (84) Designated Contracting States: • SCHIESTL, Robert, H. AL AT BE BG CH CY CZ DE DK EE ES FI FR GB Encino, CA California 91436 (US) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO • RELIENE, Ramune PL PT RO RS SE SI SK SM TR Los Angeles, CA California 90024 (US) • BORNEMAN, James (30) Priority: 22.02.2013 US 201361956186 P Riverside, CA California 92506 (US) 26.11.2013 US 201361909242 P • PRESLEY, Laura, L. Santa Maria, CA California 93458 (US) (62) Document number(s) of the earlier application(s) in • BRAUN, Jonathan accordance with Art. 76 EPC: Tarzana, CA California 91356 (US) 14753847.4 / 2 958 575 (74) Representative: Müller-Boré & Partner (71) Applicant: The Regents of the University of Patentanwälte PartG mbB California Friedenheimer Brücke 21 Oakland, CA 94607 (US) 80639 München (DE) (72) Inventors: Remarks: • YAMAMOTO, Mitsuko, L. This application was filed on 27-03-2019 as a Alameda, CA California 94502 (US) divisional application to the application mentioned under INID code 62. (54) FOOD OR BEVERAGE PRODUCT, OR PROBIOTIC COMPOSITION, COMPRISING LACTOBACILLUS JOHNSONII 456 (57) The present invention relates to food products, beverage products and probiotic compositions comprising Lacto- bacillus johnsonii 456. EP 3 536 328 A1 Printed by Jouve, 75001 PARIS (FR) EP 3 536 328 A1 Description CROSS-REFERENCE TO RELATED APPLICATIONS 5 [0001] This application claims the benefit of U.S.
    [Show full text]
  • WO 2018/064165 A2 (.Pdf)
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/064165 A2 05 April 2018 (05.04.2018) W !P O PCT (51) International Patent Classification: Published: A61K 35/74 (20 15.0 1) C12N 1/21 (2006 .01) — without international search report and to be republished (21) International Application Number: upon receipt of that report (Rule 48.2(g)) PCT/US2017/053717 — with sequence listing part of description (Rule 5.2(a)) (22) International Filing Date: 27 September 2017 (27.09.2017) (25) Filing Language: English (26) Publication Langi English (30) Priority Data: 62/400,372 27 September 2016 (27.09.2016) US 62/508,885 19 May 2017 (19.05.2017) US 62/557,566 12 September 2017 (12.09.2017) US (71) Applicant: BOARD OF REGENTS, THE UNIVERSI¬ TY OF TEXAS SYSTEM [US/US]; 210 West 7th St., Austin, TX 78701 (US). (72) Inventors: WARGO, Jennifer; 1814 Bissonnet St., Hous ton, TX 77005 (US). GOPALAKRISHNAN, Vanch- eswaran; 7900 Cambridge, Apt. 10-lb, Houston, TX 77054 (US). (74) Agent: BYRD, Marshall, P.; Parker Highlander PLLC, 1120 S. Capital Of Texas Highway, Bldg. One, Suite 200, Austin, TX 78746 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • Assessment of Host Genetics and Environmental Factors in Shaping the Gut Microbiota
    Assessment of host genetics and environmental factors in shaping the gut microbiota Von der Fakultät für Lebenswissenschaften der Technischen Universität Carolo-Wilhelmina zu Braunschweig zur Erlangung des Grades eines Doktors der Naturwissenschaften (Dr. rer. nat.) genehmigte D i s s e r t a t i o n von Eric Juan Carlos Gálvez Bobadilla aus Fusagasugá / Kolumbien 1. Referentin: Professorin Dr. Petra Dersch 2. Referent: Professor Dr. Karsten Hiller eingereicht am: 01.10.2018 mündliche Prüfung (Disputation) am: 12.12.2018 Druckjahr 2019 Vorveröffentlichungen der Dissertation Teilergebnisse aus dieser Arbeit wurden mit Genehmigung der Fakultät für Lebenswissenschaften, vertreten durch die Mentorin der Arbeit, in folgenden Beiträgen vorab veröffentlicht: Publikationen Gálvez EJC*, Iljazovic A, Gronow A, Flavell RA, Strowig T**. Shaping of intestinal microbiota in Nlrp6 and Rag2 deficient mice depends on community structure. Cell Rep. (2017). * First author, **Corresponding author Tagungsbeiträge Eric J.C Gálvez and Till Strowig: Low Complexity Microbiota mice (LCM) A stable and defined gut microbiota to study host-microbial interactions (Oral Presentation). 7th Seeon Conference on „Microbiota, Probiota and Host“, 04-06 July 2014. Kloster Seeon, Germany. Eric J.C Gálvez and Till Strowig: Composition and functional dynamics of novel gut commensal species of Prevotella (Oral Presentation). EMBO|FEBS Lecture course: The new microbiology, 24 August – 1 September 2016. Spetses, Greece. Acknowledgments I would like to express my deep gratitude to my mentor, Dr. Till Strowig, for his constant support during the past years. Thank you for your patient guidance, enthusiastic encouragement and all the great advice without which this thesis would have not been possible.
    [Show full text]
  • Genomics of Helicobacter Species 91
    Genomics of Helicobacter Species 91 6 Genomics of Helicobacter Species Zhongming Ge and David B. Schauer Summary Helicobacter pylori was the first bacterial species to have the genome of two independent strains completely sequenced. Infection with this pathogen, which may be the most frequent bacterial infec- tion of humanity, causes peptic ulcer disease and gastric cancer. Other Helicobacter species are emerging as causes of infection, inflammation, and cancer in the intestine, liver, and biliary tract, although the true prevalence of these enterohepatic Helicobacter species in humans is not yet known. The murine pathogen Helicobacter hepaticus was the first enterohepatic Helicobacter species to have its genome completely sequenced. Here, we consider functional genomics of the genus Helico- bacter, the comparative genomics of the genus Helicobacter, and the related genera Campylobacter and Wolinella. Key Words: Cytotoxin-associated gene; H-Proteobacteria; gastric cancer; genomic evolution; genomic island; hepatobiliary; peptic ulcer disease; type IV secretion system. 1. Introduction The genus Helicobacter belongs to the family Helicobacteriaceae, order Campylo- bacterales, and class H-Proteobacteria, which is also known as the H subdivision of the phylum Proteobacteria. The H-Proteobacteria comprise of a relatively small and recently recognized line of descent within this extremely large and phenotypically diverse phy- lum. Other genera that colonize and/or infect humans and animals include Campylobac- ter, Arcobacter, and Wolinella. These organisms are all microaerophilic, chemoorgano- trophic, nonsaccharolytic, spiral shaped or curved, and motile with a corkscrew-like motion by means of polar flagella. Increasingly, free living H-Proteobacteria are being recognized in a wide range of environmental niches, including seawater, marine sedi- ments, deep-sea hydrothermal vents, and even as symbionts of shrimp and tubeworms in these environments.
    [Show full text]
  • Diagnostic Assay for Helicobacter Hepaticus Based on Nucleotide Sequence of Its 16S Rrna Gene JANE K
    JOURNAL OF CLINICAL MICROBIOLOGY, May 1995, p. 1344–1347 Vol. 33, No. 5 0095-1137/95/$04.0010 Copyright q 1995, American Society for Microbiology Diagnostic Assay for Helicobacter hepaticus Based on Nucleotide Sequence of Its 16S rRNA Gene JANE K. BATTLES,1 JAMES C. WILLIAMSON,1 KRISTEN M. PIKE,1 PETER L. GORELICK,2 3 1 JERROLD M. WARD, AND MATTHEW A. GONDA * Laboratory of Cell and Molecular Structure1 and Laboratory Animal Sciences Program,2 Program Resources, Inc./DynCorp, and Veterinary and Tumor Pathology Section, Office of Laboratory Animal Science,3 National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201 Received 17 November 1994/Returned for modification 3 January 1995/Accepted 7 February 1995 Conserved primers were used to PCR amplify 95% of the Helicobacter hepaticus 16S rRNA gene. Its sequence was determined and aligned to those of related bacteria, enabling the selection of primers to highly diverged regions of the 16S rRNA gene and an oligonucleotide probe for the development of a PCR-liquid hybridization assay. This assay was shown to be both sensitive and specific for H. hepaticus 16S rRNA gene sequences. Helicobacter hepaticus is a recently identified species of Helicobacter canis (34). Many PCR-based techniques have gram-negative, microaerophilic, urease-positive, spiral bacte- been developed to amplify 16S rRNA sequences of H. pylori rium that was originally isolated from the livers of mice with and related organisms (3, 6, 15, 16, 20, 24, 39, 44). chronic active hepatitis at the National Cancer Institute-Fred- In the present report, the objective was to develop a species- erick Cancer Research and Development Center.
    [Show full text]
  • The Molecular Phylogeny and Ecology of Spiral Bacteria from the Mouse Gastrointestinal Tract
    The Molecular Phylogeny and Ecology of Spiral Bacteria from the Mouse Gastrointestinal Tract Bronwyn Ruth Robertson A thesis submitted for the degree of Doctor of Philosophy School of Microbiology and Immunology The University of New South Wales Sydney, Australia May, 1998 'Brief rejfection on test-tu.ies 'Ta~ a piece offire, a piece ofwater, a piece of ra66it or a piece of tree, or any piece ofa liuman 6eing, ~ it, slia~ it, stopper it up, k.._eep it wann, in tlie tfarl<:.i in tlie Bglit, refrigerate/, fet it stantf stifffor a wliife - yourselves far from stiff- 6ut that's tlie realjo~. Jtjter a wliife you wok.._- ~ntf it's growing, a fittfe ocean, a fittle vofcano, a fittfe tree, a fittfe lieart, a fittfe 6rain, so fittfe you don't liear it lamenting as it wants to get out, 6ut that's tlie reafjo~, not liearing it. 'Ift.engo ·antf record it, a[[ tfaslies or a[[ crosses, some witli ~famation-mar/&, a[[ nouglits antf a[[figures, some witli ~famation-marf&, antf that's tlie reafjo~, in effect a test-tu6e is a device for changing nouglits into ~famation mar/&. 'Iliat's tlie reafJo~ wliicli mak.._es you forget for a wliile tliat reaffy you yourself are In tlie test-tu6e Mirosfav !Jfo{u6 Poems 'Before arufJtfter Acknowledgements I extend my grateful thanks to the following people for their assistance and encouragement during my PhD studies. Professor Adrian Lee for giving me the opportunity to carry out my PhD in his laboratory, for his supervision and for his enthusiasm for the "other helicobacters".
    [Show full text]
  • The Year in Helicobacter 2020
    EDITOR: David Y. Graham, M.D. The Year in Helicobacter 2020 Guest Editors: Francis Mégraud & Peter Malfertheiner Online only from 2011 The Year in Helicobacter XXXIIIrd Internaঞ onal Workshop on Helicobacter & Microbiota in Infl ammaঞ on & Cancer Virtual Conference September 12, 2020 Guest editors: Francis Mégraud & Peter Malfertheiner This publicaঞ on has been supported by European Helicobacter and Microbiota Study Group Helicobacter VOLUME 25 SUPPLEMENT 1 SEPTEMBER 2020 CONTENTS REVIEW ARTICLES e12734 Review: Epidemiology of Helicobacter pylori Linda Mezmale, Luiz Gonzaga Coelho, Dmitry Bordin and Marcis Leja e12735 Review: Diagnosis of Helicobacter pylori infecঞ on Gauri Godbole, Francis Mégraud and Emilie Bessède e12736 Review: Pathogenesis of Helicobacter pylori infecঞ on Milica Denic, Elie e Touaࢼ and Hilde De Reuse e12737 Review - Helicobacter, infl ammaঞ on, immunology and vaccines Karen Robinson and Philippe Lehours e12738 Review - Helicobacter pylori and non-malignant upper gastro-intesঞ nal diseases Chrisࢼ an Schulz and Juozas Kupcˇinskas e12739 Review: Gastric cancer: Basic aspects Carlos Resende, Carla Pereira Gomes and Jose Carlos Machado e12740 Review: Prevenঞ on and management of gastric cancer Marino Venerito, Alexander C. Ford, Theodoros Rokkas and Peter Malfertheiner e12741 Review: Extragastric diseases and Helicobacter pylori Rinaldo Pellicano, Gianluca Ianiro, Sharmila Fagoonee, Carlo R. Se anni and Antonio Gasbarrini e12742 Review: Helicobacter pylori infecঞ on in children Ji-Hyun Seo, Kristen Bortolin and Nicola L.
    [Show full text]
  • List of the Pathogens Intended to Be Controlled Under Section 18 B.E
    (Unofficial Translation) NOTIFICATION OF THE MINISTRY OF PUBLIC HEALTH RE: LIST OF THE PATHOGENS INTENDED TO BE CONTROLLED UNDER SECTION 18 B.E. 2561 (2018) By virtue of the provision pursuant to Section 5 paragraph one, Section 6 (1) and Section 18 of Pathogens and Animal Toxins Act, B.E. 2558 (2015), the Minister of Public Health, with the advice of the Pathogens and Animal Toxins Committee, has therefore issued this notification as follows: Clause 1 This notification is called “Notification of the Ministry of Public Health Re: list of the pathogens intended to be controlled under Section 18, B.E. 2561 (2018).” Clause 2 This Notification shall come into force as from the following date of its publication in the Government Gazette. Clause 3 The Notification of Ministry of Public Health Re: list of the pathogens intended to be controlled under Section 18, B.E. 2560 (2017) shall be cancelled. Clause 4 Define the pathogens codes and such codes shall have the following sequences: (1) English alphabets that used for indicating the type of pathogens are as follows: B stands for Bacteria F stands for fungus V stands for Virus P stands for Parasites T stands for Biological substances that are not Prion R stands for Prion (2) Pathogen risk group (3) Number indicating the sequence of each type of pathogens Clause 5 Pathogens intended to be controlled under Section 18, shall proceed as follows: (1) In the case of being the pathogens that are utilized and subjected to other law, such law shall be complied. (2) Apart from (1), the law on pathogens and animal toxin shall be complied.
    [Show full text]
  • Mouse Models for Human Intestinal Microbiota Research: a Critical Evaluation
    Cell. Mol. Life Sci. (2018) 75:149–160 https://doi.org/10.1007/s00018-017-2693-8 Cellular and Molecular LifeSciences MULTI-AUTHOR REVIEW Mouse models for human intestinal microbiota research: a critical evaluation Floor Hugenholtz1,3 · Willem M. de Vos1,2 Received: 25 September 2017 / Accepted: 29 September 2017 / Published online: 9 November 2017 © The Author(s) 2017. This article is an open access publication Abstract Since the early days of the intestinal microbi- data. This may afect the reproducibility of mouse micro- ota research, mouse models have been used frequently to biota studies and their conclusions. Hence, future studies study the interaction of microbes with their host. However, should take these into account to truly show the efect of to translate the knowledge gained from mouse studies to diet, genotype or environmental factors on the microbial a human situation, the major spatio-temporal similarities composition. and diferences between intestinal microbiota in mice and humans need to be considered. This is done here with spe- Keywords Microbiome · Metagenome · Phylogeny · cifc attention for the comparative physiology of the intes- Murine models · Reproducibility · Diet tinal tract, the efect of dietary patterns and diferences in genetics. Detailed phylogenetic and metagenomic analysis showed that while many common genera are found in the Introduction human and murine intestine, these difer strongly in abun- dance and in total only 4% of the bacterial genes are found In adult life, a healthy human may harbor several hundreds to share considerable identity. Moreover, a large variety of diferent microbial species in their intestine, which col- of murine strains is available yet most of the microbiota lectively encode more than 100-fold more non-redundant research is performed in wild-type, inbred strains and their genes than there are in the human genome [1–3].
    [Show full text]
  • Helicobacter Pullorum As a Cause of Enterohepatic
    Table of contents _________________________________________________________________________________________ List of abbreviations 2 Scientific background 4 Enterohepatic Helicobacter species: a review of the literature 6 Scientific aims 48 Experimental studies Chapter 1 The agent Helicobacter pullorum: prevalence and in vitro susceptibility to different antimicrobial agents 50 1.1 Occurrence of Helicobacter pullorum in broiler chickens and comparison of isolates using amplified fragment length polymorphism profiling 52 1.2 Prevalence of Helicobacter pullorum among patients with gastrointestinal disease and clinically healthy persons 70 1.3 In vitro susceptibility of Helicobacter pullorum isolates to different antimicrobial agents 84 Chapter 2 Study of bacteria-host interactions 100 2.1 In vitro testing of virulence markers in Helicobacter pullorum 102 2.1.1 The cytolethal distending toxin among Helicobacter pullorum isolates from human and poultry origin 104 2.1.2 Cell death by mitotic catastrophe in mouse liver cells caused by Helicobacter pullorum 128 2.2 In vivo interaction of poultry and human Helicobacter pullorum isolates with broiler chickens 152 General discussion 174 Summary 194 Samenvatting 200 Author’s curriculum 206 Dankwoord 212 1 List of abbreviations _________________________________________________________________________________________ AFLP amplified fragment length polymorphism ATCC American Type Culture Collection ATM ataxia telangiectasia mutated ATP adenosine triphosphate ATR ATM and Rad3 related BHI brain heart
    [Show full text]
  • Biosafety Guidelines for Contained Use of Genetically Modified Microorganisms at Pilot and Industrial Scales
    Biosafety Guidelines for Contained Use of Genetically Modified Microorganisms at Pilot and Industrial Scales TECHNICAL BIOSAFETY COMMITTEE (TBC) NATIONAL CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY (BIOTEC) NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY (NSTDA) MINISTRY OF SCIENCE AND TECHNOLOGY (MOST) 2015 Biosafety Guidelines for Contained Use of Genetically Modified Microorganisms at Pilot and Industrial Scales TECHNICAL BIOSAFETY COMMITTEE (TBC) NATIONAL CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY (BIOTEC) NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY (NSTDA) MINISTRY OF SCIENCE AND TECHNOLOGY (MOST) 2015 Biosafety Guidelines for Contained Use of Genetically Modified Microorganisms at Pilot and Industrial Scales Technical Biosafety Committee National Center for Genetic Engineering and Biotechnology National Science and Technology Development Agency (NSTDA) © National Center for Genetic Engineering and Biotechnology 2015 ISBN : 978-616-12-0386-3 Tel : +66(0)2-564-6700 Fax : +66(0)2-564-6703 E-mail : [email protected] URL : http://www.biotec.or.th Printing House : P.A. Living Printing Co.,Ltd 4 Soi Sirintron 7 Road Sirintron District Bangplad Province Bangkok 10700 Tel : +66(0)2-881 9890 Fax : +66(0)2-881 9894 Preface Genetically Modified Microorganisms (GMMs) were first used in B.E. 2525 to produce insulin in industrial medicine. Currently, GMMs are used in various industries, such as the food, pharmaceutical and bioplastic industries, to manufacture a number of important consumer products. To ensure operator and environmental safety, the Technical Biosafety Committee (TBC) of the National Center for Genetic Engineering and Biotechnology (BIOTEC), the National Science and Technology Development Agency (NSTDA), has prepared guidelines for GMM work, publishing “Biosafety Guidelines for Contained Use of Genetically Modified Microorganisms at Pilot and Industrial Scales” in B.E.
    [Show full text]
  • Bacterial Communities in Manganese Nodules in Rice Field Subsoils: Estimation Using PCR-DGGE and Sequencing Analyses
    Soil Science and Plant Nutrition (2007) 53, 575–584 doi: 10.1111/j.1747-0765.2007.00176.x ORIGINALBlackwell Publishing Ltd ARTICLE BacterialORIGINAL communities ARTICLE in manganese nodules Bacterial communities in manganese nodules in rice field subsoils: Estimation using PCR-DGGE and sequencing analyses Vita Ratri CAHYANI1,3, Jun MURASE1, Eiji ISHIBASHI2, Susumu ASAKAWA1 and Makoto KIMURA1 1Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, 2Agricultural Experiment Station, Okayama Prefectural General Agricultural Center, Okayama 709-0801, Japan; and 3Faculty of Agriculture, Sebelas Maret University, Surakarta 57126, Indonesia Abstract The phylogenetic positions of bacterial communities in manganese (Mn) nodules from subsoils of two Japanese rice fields were estimated using polymerase chain reaction-denaturing gradient gel electrophoresis (PCR- DGGE) analysis followed by sequencing of 16S rDNA. The DGGE band patterns and sequencing analysis of characteristic DGGE bands revealed that the bacterial communities in Mn nodules were markedly different from those in the plow layer and subsoils. Three out of four common bands found in Mn nodules from two sites corresponded to Deltaproteobacteria and were characterized as sulfate-reducing and iron-reducing bacteria. The other DGGE bands of Mn nodules corresponded to sulfate and iron reducers (Deltaproteo- bacteria), methane-oxidizing bacteria (Gamma and Alphaproteobacteria), nitrite-oxidizing bacteria (Nitrospirae) and Actinobacteria. In addition, some DGGE bands of Mn nodules showed no clear affiliation to any known bacteria. The present study indicates that members involved in the reduction of Mn nodules dominate the bacterial communities in Mn nodules in rice field subsoils. Key words: bacteria, manganese nodule, manganese reduction, phylogeny, rice field. INTRODUCTION The sites of Fe and Mn accumulation in the subsoil layer are termed Fe and Mn illuvial horizons, and the Rice is a staple crop in Asian countries.
    [Show full text]